Thach A B, Dugel P U, Flindall R J, Sipperley J O, Sneed S R
Walter Reed Army Medical Center, Washington, DC, USA.
Ophthalmology. 1997 Dec;104(12):2003-8. doi: 10.1016/s0161-6420(97)30065-7.
The objective is to compare the effectiveness of retrobulbar and posterior sub-Tenon's injection of corticosteroids for treatment of post-cataract cystoid macular edema that was refractory to topical medications.
A retrospective study was performed.
A total of 48 patients (49 eyes) with post-cataract cystoid macular edema refractory to topical medications was studied.
Patients received either a single retrobulbar injection (18 eyes) or 3 biweekly posterior sub-Tenon's injections (31 eyes) of corticosteroids.
Patients were observed for clinical resolution of the cystoid macular edema, visual acuity, and intraocular pressure.
Both treatment methods resulted in significant improvement in visual acuity. The posterior sub-Tenon's group had a visual improvement from 20/92 pretreatment to 20/50 post-treatment (P = 0.0001) with a median follow-up of 12 months. The retrobulbar group had a visual improvement from 20/97 pretreatment to 20/58 post-treatment (P = 0.035) with a median follow-up of 10 months. The visual improvement was not significantly different between the two groups. The average intraocular pressure increased from a pretreatment level of 14.1 mmHg to a high of 17.7 mmHg (P < 0.00005) in the sub-Tenon's group. The average intraocular pressure increased from 15.1 mmHg to a high of 17.6 mmHg (P = 0.04) in the retrobulbar group.
Cystoid macular edema that persists after treatment with topical medications may improve after retrobulbar or posterior sub-Tenon's corticosteroid injections. There was no significant difference in outcome between the two treatment groups.
比较球后注射和Tenon囊下注射皮质类固醇治疗对局部用药难治的白内障后囊样黄斑水肿的有效性。
进行一项回顾性研究。
共研究了48例(49只眼)对局部用药难治的白内障后囊样黄斑水肿患者。
患者接受单次球后注射皮质类固醇(18只眼)或每两周进行3次Tenon囊下注射皮质类固醇(31只眼)。
观察患者囊样黄斑水肿的临床消退情况、视力和眼压。
两种治疗方法均使视力有显著改善。Tenon囊下注射组在中位随访12个月时,视力从治疗前的20/92提高到治疗后的20/50(P = 0.0001)。球后注射组在中位随访10个月时,视力从治疗前的20/97提高到治疗后的20/58(P = 0.035)。两组之间的视力改善无显著差异。Tenon囊下注射组的平均眼压从治疗前的14.1 mmHg升高至最高17.7 mmHg(P < 0.00005)。球后注射组的平均眼压从15.1 mmHg升高至最高17.6 mmHg(P = 0.04)。
局部用药治疗后持续存在的囊样黄斑水肿在球后或Tenon囊下注射皮质类固醇后可能改善。两个治疗组的疗效无显著差异。